### Bayesian Analysis of Population PK/PD Models: General Concepts and Software

暂无分享，去创建一个

Jon Wakefield | David J. Spiegelhalter | David J. Lunn | Nicky Best | David Lunn | Andrew W. Thomas | D. Spiegelhalter | J. Wakefield | N. Best | Andrew Thomas

[1] Adrian F. M. Smith,et al. Bayesian Analysis of Linear and Non‐Linear Population Models by Using the Gibbs Sampler , 1994 .

[2] K. Cowles,et al. CODA: convergence diagnosis and output analysis software for Gibbs sampling output , 1995 .

[3] Brian D. Ripley,et al. Stochastic Simulation , 2005 .

[4] David J. Lunn,et al. The Pharmacokinetics of Saquinavir: A Markov Chain Monte Carlo Population Analysis , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[5] Andrew Gelman,et al. General methods for monitoring convergence of iterative simulations , 1998 .

[6] David J. Spiegelhalter,et al. Bayesian analysis in expert systems , 1993 .

[7] Philip C. Spector. Introduction to S and S-Plus , 1995 .

[8] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[9] G. Grimmett,et al. Probability and random processes , 2002 .

[10] R. Kass,et al. Reference Bayesian Methods for Generalized Linear Mixed Models , 2000 .

[11] Sylvia Richardson,et al. Markov Chain Monte Carlo in Practice , 1997 .

[12] Walter R. Gilks,et al. Full conditional distributions , 1995 .

[13] David J. Lunn,et al. Markov Chain Monte Carlo Techniques for Studying Interoccasion and Intersubject Variability: Application to Pharmacokinetic Data , 1997 .

[14] David B. Dunson,et al. Bayesian Data Analysis , 2010 .

[15] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[16] Steffen L. Lauritzen,et al. Independence properties of directed markov fields , 1990, Networks.

[17] M. O. Karlsson,et al. The importance of modeling interoccasion variability in population pharmacokinetic analyses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[18] Donald Geman,et al. Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images , 1984 .

[19] W. Gilks,et al. Adaptive Rejection Sampling for Gibbs Sampling , 1992 .

[20] G. B. Smith,et al. Preface to S. Geman and D. Geman, “Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images” , 1987 .

[21] L Aarons,et al. Software for Population Pharmacokinetics and Pharmacodynamics , 1999, Clinical pharmacokinetics.

[22] Dani Gamerman,et al. Statistical inference : an integrated approach , 1999 .

[23] Stuart L. Beal,et al. Ways to Fit a PK Model with Some Data Below the Quantification Limit , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[24] M. Kenward,et al. Informative Drop‐Out in Longitudinal Data Analysis , 1994 .

[25] Adrian Dunne,et al. Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials , 1997 .

[26] A. Gelfand,et al. Inequalities between expected marginal log‐likelihoods, with implications for likelihood‐based model complexity and comparison measures , 2003 .

[27] J. E. Bennett,et al. A comparison of a bayesian population method with two methods as implemented in commercially available software , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[28] Radford M. Neal. Markov Chain Monte Carlo Methods Based on `Slicing' the Density Function , 1997 .

[29] Christian P. Robert,et al. MCMC Convergence Diagnostics : A « Reviewww » , 1998 .

[30] A. P. Dawid,et al. Independence properties of directed Markov fields. Networks, 20, 491-505 , 1990 .

[31] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[32] H. Akaike. A new look at the statistical model identification , 1974 .

[33] David J. Spiegelhalter,et al. Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[34] Radford M. Neal,et al. Suppressing Random Walks in Markov Chain Monte Carlo Using Ordered Overrelaxation , 1995, Learning in Graphical Models.

[35] D. Rubin,et al. Inference from Iterative Simulation Using Multiple Sequences , 1992 .

[36] J. Q. Smith,et al. 1. Bayesian Statistics 4 , 1993 .

[37] P. Green. Reversible jump Markov chain Monte Carlo computation and Bayesian model determination , 1995 .

[38] Bradley P. Carlin,et al. Markov Chain Monte Carlo conver-gence diagnostics: a comparative review , 1996 .

[39] D. Spiegelhalter,et al. Bayesian Analysis of Realistically Complex Models , 1996 .

[40] A W Kelman,et al. Population pharmacokinetics of gentamicin in neonates. , 1988, Developmental pharmacology and therapeutics.

[41] Jon Wakefield,et al. An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .

[42] Adelchi Azzalini,et al. Statistical Inference: An Integrated Approach. Helio S. Migon and Dani Gamerman, Arnold, London, 1999. No. of pages: ix+262. Price: £24.99. ISBN 0‐340‐740590 , 2001 .

[43] J. Besag,et al. Bayesian Computation and Stochastic Systems , 1995 .

[44] Kerrie Mengersen,et al. [Bayesian Computation and Stochastic Systems]: Rejoinder , 1995 .

[45] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .